Publication

Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia

Wasir, R., Irawati, S., Makady, A., Postma, M. J., Goettsch, W., Feenstra, T. L. & Buskens, E., Oct-2018, p. S184. 1 p.

Research output: Contribution to conferenceAbstractAcademic

APA

Wasir, R., Irawati, S., Makady, A., Postma, M. J., Goettsch, W., Feenstra, T. L., & Buskens, E. (2018). Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia. S184. https://doi.org/10.1016/j.jval.2018.09.1099

Author

Wasir, R. ; Irawati, S. ; Makady, A. ; Postma, M.J. ; Goettsch, W. ; Feenstra, Talitha L ; Buskens, E. / Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia. 1 p.

Harvard

Wasir, R, Irawati, S, Makady, A, Postma, MJ, Goettsch, W, Feenstra, TL & Buskens, E 2018, 'Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia' pp. S184. https://doi.org/10.1016/j.jval.2018.09.1099

Standard

Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia. / Wasir, R.; Irawati, S.; Makady, A.; Postma, M.J.; Goettsch, W.; Feenstra, Talitha L; Buskens, E.

2018. S184.

Research output: Contribution to conferenceAbstractAcademic

Vancouver

Wasir R, Irawati S, Makady A, Postma MJ, Goettsch W, Feenstra TL et al. Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia. 2018. https://doi.org/10.1016/j.jval.2018.09.1099


BibTeX

@conference{b9a3f22c6cf84bdd8bf0c390e78f8ede,
title = "Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia",
abstract = "Objectives: This study aimed to identify the barriers and facilitators of the utilization of health technology assessment (HTA), a process which is infrequently applied to the selection of medicines listed in the medicine pricing and reimbursement policies in Indonesia. Methods: Semi-structured interviews were conducted to collect qualitative data. Purposive sampling was used to recruit the stakeholders, which consisted of policymakers, a pharmaceutical industry representative, healthcare providers, and patients. The data were analyzed using directed content analysis to systematically organize the data into a structured format. A COnsolidated criteria for REporting Qualitative studies (COREQ) checklist was followed to ensure a high quality and comprehensive report of the findings. Results: The twenty-five participants interviewed provided a range of barriers and promoting factors for the implementation of HTA in Indonesia. A lack of capability of local human resources, a lack of incentives, unintegrated data, as well as a lack of a clear framework were mentioned as barriers. An important promoting factor was seen in the Indonesian law which stipulated that HTA was mandatory for selecting medicines listed in the medicine pricing and reimbursement policies. Strategies suggested to overcome the barriers include setting up an HTA department in several Indonesian universities, introducing a clear framework for the implementation of HTA in the guidelines, and establishing relationships with other countries with a well-developed HTA or with HTA associations. Conclusions: Several barriers are currently preventing the implementation of HTA in medicine pricing and reimbursement policy in Indonesia, however, solutions to these issues exist.",
keywords = "adult, biomedical technology assessment, checklist, clinical article, conference abstract, content analysis, drug industry, female, health care personnel, human, Indonesia, male, practice guideline, qualitative research, reimbursement, sampling, semi structured interview",
author = "R. Wasir and S. Irawati and A. Makady and M.J. Postma and W. Goettsch and Feenstra, {Talitha L} and E. Buskens",
year = "2018",
month = "10",
doi = "10.1016/j.jval.2018.09.1099",
language = "English",
pages = "S184",

}

RIS

TY - CONF

T1 - Barriers to and facilitators of the application of health technology assessment in medicine pricing and reimbursement policies in indonesia

AU - Wasir, R.

AU - Irawati, S.

AU - Makady, A.

AU - Postma, M.J.

AU - Goettsch, W.

AU - Feenstra, Talitha L

AU - Buskens, E.

PY - 2018/10

Y1 - 2018/10

N2 - Objectives: This study aimed to identify the barriers and facilitators of the utilization of health technology assessment (HTA), a process which is infrequently applied to the selection of medicines listed in the medicine pricing and reimbursement policies in Indonesia. Methods: Semi-structured interviews were conducted to collect qualitative data. Purposive sampling was used to recruit the stakeholders, which consisted of policymakers, a pharmaceutical industry representative, healthcare providers, and patients. The data were analyzed using directed content analysis to systematically organize the data into a structured format. A COnsolidated criteria for REporting Qualitative studies (COREQ) checklist was followed to ensure a high quality and comprehensive report of the findings. Results: The twenty-five participants interviewed provided a range of barriers and promoting factors for the implementation of HTA in Indonesia. A lack of capability of local human resources, a lack of incentives, unintegrated data, as well as a lack of a clear framework were mentioned as barriers. An important promoting factor was seen in the Indonesian law which stipulated that HTA was mandatory for selecting medicines listed in the medicine pricing and reimbursement policies. Strategies suggested to overcome the barriers include setting up an HTA department in several Indonesian universities, introducing a clear framework for the implementation of HTA in the guidelines, and establishing relationships with other countries with a well-developed HTA or with HTA associations. Conclusions: Several barriers are currently preventing the implementation of HTA in medicine pricing and reimbursement policy in Indonesia, however, solutions to these issues exist.

AB - Objectives: This study aimed to identify the barriers and facilitators of the utilization of health technology assessment (HTA), a process which is infrequently applied to the selection of medicines listed in the medicine pricing and reimbursement policies in Indonesia. Methods: Semi-structured interviews were conducted to collect qualitative data. Purposive sampling was used to recruit the stakeholders, which consisted of policymakers, a pharmaceutical industry representative, healthcare providers, and patients. The data were analyzed using directed content analysis to systematically organize the data into a structured format. A COnsolidated criteria for REporting Qualitative studies (COREQ) checklist was followed to ensure a high quality and comprehensive report of the findings. Results: The twenty-five participants interviewed provided a range of barriers and promoting factors for the implementation of HTA in Indonesia. A lack of capability of local human resources, a lack of incentives, unintegrated data, as well as a lack of a clear framework were mentioned as barriers. An important promoting factor was seen in the Indonesian law which stipulated that HTA was mandatory for selecting medicines listed in the medicine pricing and reimbursement policies. Strategies suggested to overcome the barriers include setting up an HTA department in several Indonesian universities, introducing a clear framework for the implementation of HTA in the guidelines, and establishing relationships with other countries with a well-developed HTA or with HTA associations. Conclusions: Several barriers are currently preventing the implementation of HTA in medicine pricing and reimbursement policy in Indonesia, however, solutions to these issues exist.

KW - adult

KW - biomedical technology assessment

KW - checklist

KW - clinical article

KW - conference abstract

KW - content analysis

KW - drug industry

KW - female

KW - health care personnel

KW - human

KW - Indonesia

KW - male

KW - practice guideline

KW - qualitative research

KW - reimbursement

KW - sampling

KW - semi structured interview

U2 - 10.1016/j.jval.2018.09.1099

DO - 10.1016/j.jval.2018.09.1099

M3 - Abstract

SP - S184

ER -

ID: 75375554